AndroGel Buyers Can't Use FTC Case Against AbbVie, Besins

By P.J. D'Annunzio · March 24, 2022, 2:56 PM EDT

Drug wholesalers suing AbbVie and Besins for delaying generic Androgel from hitting the market can't stop the pharmaceutical companies from relitigating issues that the buyers said were already decided in a...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login